XML 102 R89.htm IDEA: XBRL DOCUMENT v3.22.4
Stock Based Awards and Other Equity Instruments - Summary of Stock Option Activity (Parenthetical) (Details) - $ / shares
12 Months Ended
Jul. 01, 2022
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Weighted-average grant date fair value   $ 9.93 $ 18.40 $ 10.08
Stock Options        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Options non converted into shares due to net share settlement   10,000    
Options Outstanding, Granted [1]   841,000    
Stock Options | Matt Goldberg        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Options Outstanding, Granted 516,000      
Weighted-average grant date fair value $ 9.23      
Stock awards vesting term These stock options shall vest over four years, with 25% vesting on July 1, 2023 and 6.25% of the remaining award vesting in equal quarterly installments commencing thereafter, subject to the CEO’s continuous employment with the Company.      
Requisite service period for estimated grant-date fair value of stock awards Jul. 01, 2026      
Stock Options | Tranche One | Matt Goldberg        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Options Outstanding, Granted     115,200  
Weighted-average grant date fair value     $ 12.59  
Percentage of stock based awards allowed to vest as first installment 25.00%   25.00%  
Stock Options | Tranche Two | Matt Goldberg        
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]        
Options Outstanding, Granted     110,026  
Weighted-average grant date fair value     $ 13.18  
Percentage of stock based awards allowed to vest as first installment 6.25%      
[1] Inclusive of approximately 516,000 stock options awarded to Matt Goldberg, our CEO, during July 2022. The estimated grant-date fair value per option, using a Black-Scholes option pricing model was $9.23. These stock options shall vest over four years, with 25% vesting on July 1, 2023 and 6.25% of the remaining award vesting in equal quarterly installments commencing thereafter, subject to the CEO’s continuous employment with the Company. The estimated grant-date fair value of this award will be amortized on a straight-line basis over the requisite service period through July 1, 2026.